论文部分内容阅读
目的探讨布地奈德混悬液雾化吸入在小儿肺炎治疗中的疗效。方法选择医院儿科2013年9月-2014年12月小儿肺炎患者140例,随机分成对照组和观察组各70例,对照组接受肺炎的常规治疗,观察组同时联合布地奈德混悬液雾化吸入治疗,对比2组患儿发热、咳喘症状、肺部听诊啰音消失情况、住院天数及治疗有效率。结果观察组发热、咳喘症状、肺部啰音消失情况及住院天数显著短于对照组,观察组治疗有效率91.4%优于对照组的78.6%,差异有统计学意义(P<0.05);2组均未见明显的不良反应。结论小儿肺炎常规治疗同时联合布地奈德雾化吸入,疗效确切且安全可靠,具有较高的临床应用价值。
Objective To investigate the efficacy of budesonide suspension inhalation in children with pneumonia. Methods 140 pediatric patients with pneumonia were selected from pediatric department of pediatrics from September 2013 to December 2014. They were randomly divided into control group and observation group of 70 cases each. The control group received routine treatment of pneumonia. The observation group was treated with budesonide suspension atomization Inhalation treatment, compared two groups of children with fever, cough and asthma symptoms, the disappearance of auscultation of the lungs, hospitalization days and treatment efficiency. Results The fever, cough and asthma symptoms, disappearance of pulmonary rales and days of hospital stay in observation group were significantly shorter than those in control group. The effective rate of treatment in observation group was 91.4%, which was significantly higher than that in control group (78.6%, P <0.05). No obvious adverse reactions were found in both groups. Conclusions The routine treatment of pediatric pneumonia combined with budesonide inhalation is effective, safe and reliable, and has high clinical value.